Edition:
United States

Chemed Corp (CHE.N)

CHE.N on New York Stock Exchange

236.58USD
3:15pm EST
Change (% chg)

$1.37 (+0.58%)
Prev Close
$235.21
Open
$235.21
Day's High
$237.10
Day's Low
$235.21
Volume
9,558
Avg. Vol
29,846
52-wk High
$250.45
52-wk Low
$152.09

Chart for

About

Chemed Corporation purchases, operates and divests subsidiaries engaged in various business activities. The Company operates through two segments: the VITAS segment (VITAS) and the Roto-Rooter segment (Roto-Rooter). The Company's VITAS provides hospice and palliative care services to its patients through a network of physicians,... (more)

Overall

Beta: 1.17
Market Cap(Mil.): $3,755.36
Shares Outstanding(Mil.): 15.97
Dividend: 0.28
Yield (%): 0.48

Financials

  Industry Sector
P/E (TTM): -- 29.20 15.25
EPS (TTM): -- -- --
ROI: -- 8.04 33.27
ROE: -- 11.76 16.35

BRIEF-Chemed reaches final agreement to end civil litigation & false claims act brought by U.S. DOJ in May 2013​

* Chemed - Reached final agreement to end civil litigation and false claims act brought by U.S. Department of Justice in May 2013​

Oct 31 2017

Chemed to pay $75 million over false claims lawsuit: Justice Dept

WASHINGTON Chemed Corp and subsidiaries including Vitas Hospice Services LLC and Vitas Healthcare Corp have agreed to pay $75 million to resolve a federal lawsuit alleging false claims for hospice services to Medicare, the U.S. Justice Department said on Monday.

Oct 30 2017

Chemed to pay $75 mln over false claims lawsuit -Justice Dept

WASHINGTON, Oct 30 Chemed Corp and subsidiaries including Vitas Hospice Services LLC and Vitas Healthcare Corp have agreed to pay $75 million to resolve a federal lawsuit alleging false claims for hospice services to Medicare, the U.S. Justice Department said on Monday.

Oct 30 2017

BRIEF-Chemed reports Q3 earnings per share $2.13

* Sees FY 2017 adjusted earnings per share $8.35 to $8.40 excluding items

Oct 26 2017

BRIEF-Chemed Corp increases quarterly dividend 7.7 pct

* Says declared quarterly cash dividend of 28-cents per share Source text for Eikon: Further company coverage:

Aug 04 2017

BRIEF-Chemed Corp qtrly ‍adjusted diluted eps $2.15​

* Chemed Corp qtrly ‍net patient revenue of $285 million, an increase of 2.1%​

Jul 25 2017

Earnings vs. Estimates